FITLIFE BRANDS, INC.
FTLFNasdaqHealthcare · Medicinal Chemicals & Botanical Products · NV · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $81.5M | $64.5M | $52.7M | $28.8M | $5.6M | $22.1M |
| Operating income | $10.1M | $13.1M | $7.5M | $5.7M | $1.3M | $4.3M |
| Net income | $6.3M | $9.0M | $5.3M | $4.4M | $1.4M | $8.8M |
| Total assets | $106.3M | $58.5M | $55.3M | $25.7M | $17.9M | $16.6M |
| Total liabilities | $62.7M | $22.4M | $28.3M | $4.3M | $4.5M | $4.8M |
| Equity | $43.6M | $36.1M | $27.0M | $21.4M | $13.4M | $11.9M |
| EPS (diluted) | $0.63 | $0.91 | $0.54 | $0.89 | $0.30 | $1.94 |
| Shares out. | 9.2M | 4.6M | 4.4M | 4.6M | 4.4M | 5.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 12.4%
- Net margin
- 7.8%
- Return on equity
- 14.5%
- Return on assets
- 5.9%
- Return on capital (ROCE)
- 11.9%
- Liabilities / assets
- 59.0%
- Debt / equity
- 1.44×
- Book value / share
- $4.73
- Revenue growth (YoY)
- 26.4%
- Net income growth (YoY)
- −29.6%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 2.44grey zone
- Accruals / assets
- −1.0%clean
- Beneish M-Score
- 0.56elevated
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 2 warning● 4 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Beneish M-Score elevated — earnings-manipulation screen flag
- Altman Z″ in the grey zone
- Operating margin is positive
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 16, 2022
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2022
- NT 10-Kmissed a reporting deadline ↗Mar 30, 2018
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2017
- NT 10-Qmissed a reporting deadline ↗May 15, 2017
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2017
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Askeladden Capital Management LlcPassive (13G)Feb 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Yakatan SethDirector | Jan 15, 2026 | Buy | 164 | $15.36 |
| Lingenbrink MatthewDirector | Apr 10, 2026 | Buy | 3,000 | $9.76 |
| Dawson Grant RobertDirector | Apr 10, 2026 | Buy | 3,000 | $9.98 |
| Ordal ToddDirector | Apr 15, 2025 | Buy | 300 | $12.07 |
| Lingenbrink MatthewDirector | Apr 14, 2025 | Buy | 3,000 | $12.17 |
| Lingenbrink MatthewDirector | Mar 31, 2025 | Buy | 2,800 | $12.17 |
| Dayton JuddOfficer — CHIEF EXECUTIVE OFFICER | Mar 31, 2025 | Option exercise | 144,000 | $2.62 |
| Dawson Grant RobertDirector | Mar 28, 2025 | Grant | 2,144 | $12.68 |
| Ordal ToddDirector | Jan 15, 2025 | Buy | 150 | $30.37 |
| Dayton JuddOfficer — CHIEF EXECUTIVE OFFICER | Dec 30, 2024 | Option exercise | 6,200 | $0.70 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 187,469 | 5.7 | +14.2% |
| Apr 30, 2026 | 164,196 | 5.2 | +20.6% |
| Apr 15, 2026 | 136,180 | 2.7 | +50.2% |
| Mar 31, 2026 | 90,665 | 5.1 | +22.6% |
| Mar 13, 2026 | 73,950 | 5.0 | +7.1% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Director / officer changeMay 22, 2026
- Results of operations · Regulation FD disclosureMay 14, 2026
- Regulation FD disclosureApr 7, 2026
- Results of operations · Regulation FD disclosureApr 1, 2026
- Regulation FD disclosureDec 10, 2025
- Results of operations · Regulation FD disclosureNov 13, 2025
- Regulation FD disclosureAug 19, 2025
- Results of operations · Regulation FD disclosureAug 14, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KFORM 8-KMay 22, 2026
- 4May 19, 2026
- 8-KFORM 8-KMay 14, 2026
- 10-QFORM 10-QMay 14, 2026
- 10-K/AFORM 10-K/AApr 21, 2026
- 4Apr 20, 2026
- 5Apr 20, 2026
- 4Apr 14, 2026
- 4Apr 14, 2026
- 8-KFORM 8-KApr 7, 2026
- 8-KFORM 8-KApr 1, 2026
- 10-KFORM 10-KMar 31, 2026
- 8-KFORM 8-KDec 10, 2025
- 8-KFORM 8-KNov 13, 2025
- 10-QFORM 10-QNov 13, 2025
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.